Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
Loading...

Hypera S.A.

HYPMYPNK
Healthcare
Drug Manufacturers - Specialty & Generic
$4.50
$0.00(0.00%)
U.S. Market opens in NaNh NaNm

Hypera S.A. (HYPMY) Stock Overview

Explore Hypera S.A.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap2.8B
P/E Ratio17.67
EPS (TTM)$0.25
ROE0.07%
Fundamental Analysis

AI Price Forecasts

1 Month$4.33
3 Months$5.70
1 Year Target$4.12

HYPMY Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Hypera S.A. (HYPMY) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 49.65, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $4.12.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 17.67 and a market capitalization of 2.8B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.44%
5-Day Change
2.27%
1-Month Change
-8.91%
3-Month Change
-8.54%
6-Month Change
3.45%
Year-to-Date (YTD) Change
4.17%
1-Year Change
36.36%
3-Year Change
-45.26%
5-Year Change
-23.99%
All-Time (Max) Change
-66.74%

Contact Information

55 11 3627 4206
Av. Magalhães de Castro, 4800, São Paulo, SP, 05676-120

Company Facts

10,481 Employees
IPO DateOct 15, 2010
CountryBR
Actively Trading

Frequently Asked Questions